| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 2.34 | Ki | = | 2340 | nM |
| 0.0027 | Ki | = | 2.7 | nM |
| 0.018 | Ki | = | 18 | nM |
| 1.2 | Ki | = | 1200 | nM |
| 0.442 | Ki | = | 442 | nM |
| 0.45 | Ki | = | 450 | nM |
| 0.23 | Ki | = | 230 | nM |
| 2.44 | Ki | = | 2440 | nM |
| 6.52 | Ki | = | 6520 | nM |
| 0.012 | Ki | = | 12 | nM |
| 0.89 | Ki | = | 890 | nM |
| 0.062 | Ki | = | 62 | nM |
| 10 | Ki | > | 10000 | nM |
| 6.2 | Ki | = | 6200 | nM |
| 1.6 | Ki | = | 1600 | nM |
| 0.274 | Ki | = | 274 | nM |
| 2.71 | Ki | = | 2710 | nM |
| 0.99 | Ki | = | 990 | nM |
| 0.036 | Ki | = | 36 | nM |
| 0.0031 | Ki | = | 3.1 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 317.687 | Ki | = | 317687.41 | nM | Outside typical range |
| 63.0957 | Ki | = | 63095.73 | nM | |
| 10690.5 | Ki | = | 1.069054879E7 | nM | Outside typical range |
| 5888.44 | Ki | = | 5888436.55 | nM | Outside typical range |
| 119.95 | Ki | = | 119949.93 | nM | Outside typical range |
| 897.429 | Ki | = | 897428.79 | nM | Outside typical range |
| 5767.66 | Ki | = | 5767664.63 | nM | Outside typical range |
| 352.371 | Ki | = | 352370.87 | nM | Outside typical range |
| 133.045 | Ki | = | 133045.44 | nM | Outside typical range |
| 2779.71 | Ki | = | 2779713.27 | nM | Outside typical range |
| 881.049 | Ki | = | 881048.87 | nM | Outside typical range |
| 651.628 | Ki | = | 651628.39 | nM | Outside typical range |
| 807.235 | Ki | = | 807235.03 | nM | Outside typical range |
| 4920.4 | Ki | = | 4920395.36 | nM | Outside typical range |
| 1180.32 | Ki | = | 1180320.64 | nM | Outside typical range |
| 3548.13 | Ki | = | 3548133.89 | nM | Outside typical range |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 2.34 | Ki | = | 2340 | nM |
| 0.017 | Ki | = | 17 | nM |
| 1.2 | Ki | = | 1200 | nM |
| 0.002 | Ki | = | 2 | nM |
| 0.175 | Ki | = | 175 | nM |
| 0.032 | Ki | = | 32 | nM |
| 10 | Ki | > | 10000 | nM |
| 0.003 | Ki | = | 3 | nM |
| 1.2 | Ki | = | 1200 | nM |
| 5.7 | Ki | = | 5700 | nM |
| 0.04 | Ki | = | 40 | nM |
| 6.52 | Ki | = | 6520 | nM |
| 10 | Ki | > | 10000 | nM |
| 0.062 | Ki | = | 62 | nM |
| 0.78 | Ki | = | 780 | nM |
| 1.6 | Ki | = | 1600 | nM |
| 0.225 | Ki | = | 225 | nM |
| 0.32 | Ki | = | 320 | nM |
| 0.19 | Ki | = | 190 | nM |
| 0.2 | Ki | = | 200 | nM |
| Species | Strain | IsPseudotypeVirus | AssayMeth | Target | Mutations | IC50Mod | IC50 | IC50Unit | ICOtherPct | ICOtherPctUnit | ICOtherConc | ICOtherConcUnit | KiMod | Ki | KiUnit | Km | KmUnit | HostAnalog | HostAnalogSpecies | RelResFoldChgMod | RelResFoldChg | Comments | Reference | Citation | Other Information |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 6.2 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 5.3 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 5 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | N | standard reverse transcriptase assay | Reverse transcriptase | 50 | ug/mL | SYNTHESIS AND HIV-1 REVERSE TRANSCRIPTASE INHIBITION ACTIVITY OF 1,4-NAPHTHOQUINONE DERIVATIVES. Chemistry of Natural Compounds 2012, 47(6), 883-887. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| 3'-PROCESSING | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| HIV-1 | STRAND TRANSFER | Integrase | 0.015 | uM | 19523819 | N-(4-FLUOROBENZYL)-3-HYDROXY-9;9-DIMETHYL-4-OXO-6;7;8;9-TETRAHYDRO-4H-PYRAZINO[1;2-A]PYRIMIDINE-2-CARBOXAMIDES A NOVEL CLASS OF POTENT HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2009, 19, 4245-9. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 5.8 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ASSAY | Reverse transcriptase | 170.3 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 10.2 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ASSAY | Reverse transcriptase | 33.7 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 24.9 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | 3'-processing | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . | |||||||||||||||||||
| HIV-1 | Strand Transfer | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . | |||||||||||||||||||
| HIV-1 | 3'-processing | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| pKa | = | 10.77 |
| pKa | = | 12.6 |
| pKa | = | 6.98 |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 1 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 5.2 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 7.4 | % |
| Inhibition | = | 0 | % |
| Standard Type | PubChem Standard Value | Ki | Target Accession(s) | Ligand | Target |
|---|---|---|---|---|---|
| Ki | 548 | 548000 | P09871 | BDBM93095 | Complement C1s subcomponent |
| Ki | 2970 | 2970000 | P09871 | BDBM93096 | Complement C1s subcomponent |
| Ki | 4370 | 4370000 | P09871 | BDBM93097 | Complement C1s subcomponent |
| Ki | 92500 | 92500000 | P09871 | BDBM93099 | Complement C1s subcomponent |
| Ki | 1120 | 1120000 | P09871 | BDBM93101 | Complement C1s subcomponent |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 38.8 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 0 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 0 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0 | % |
| Inhibition | = | 3.5 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| Inhibition | = | 0.766 | % |
| Inhibition | < | 10 | % |
| Inhibition | < | 10 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 74 | IC50 | = | 74000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 13 | IC50 | = | 13000 | nM |
| 32 | IC50 | = | 32000 | nM |
| 2.2 | IC50 | = | 2200 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 100 | IC50 | > | 100000 | nM |
| 80 | IC50 | = | 80000 | nM |
| 63 | IC50 | = | 63000 | nM |
| 4.8 | IC50 | = | 4800 | nM |
| 9.3 | IC50 | = | 9300 | nM |
| 1 | IC50 | = | 1000 | nM |
| 0.15 | IC50 | = | 150 | nM |
| 0.42 | IC50 | = | 420 | nM |
| 0.018 | IC50 | = | 18 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 15.6 | Ki | = | 15600 | nM | |
| 6.49 | Ki | = | 6490 | nM | |
| 419 | Ki | = | 419000 | nM | Outside typical range |
| 676 | Ki | = | 676000 | nM | Outside typical range |
| 6.07 | Ki | = | 6070 | nM | |
| 103 | Ki | = | 103000 | nM | Outside typical range |
| 90.7 | Ki | = | 90700 | nM | |
| 20.6 | Ki | = | 20600 | nM | |
| 54.3 | Ki | = | 54300 | nM | |
| 30.7 | Ki | = | 30700 | nM | |
| 136 | Ki | = | 136000 | nM | Outside typical range |
| 1450 | Ki | = | 1450000 | nM | Outside typical range |
| 72.4 | Ki | = | 72400 | nM | |
| 1330 | Ki | = | 1330000 | nM | Outside typical range |
| 388 | Ki | = | 388000 | nM | Outside typical range |
| 259 | Ki | = | 259000 | nM | Outside typical range |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 2.8 | IC50 | = | 2800 | nM | |
| 452.5 | IC50 | = | 452500 | nM | Outside typical range |
| 4.8 | IC50 | = | 4800 | nM | |
| 27.8 | IC50 | = | 27800 | nM | |
| 2.2 | IC50 | = | 2200 | nM | |
| 1.5 | IC50 | = | 1500 | nM |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Ratio IC50 | = | 8 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | = | 6 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| Ratio IC50 | < | 5 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 15.5955 | Ki | = | 15595.53 | nM | |
| 6.48634 | Ki | = | 6486.34 | nM | |
| 418.794 | Ki | = | 418793.57 | nM | Outside typical range |
| 676.083 | Ki | = | 676082.98 | nM | Outside typical range |
| 6.06736 | Ki | = | 6067.36 | nM | |
| 103.039 | Ki | = | 103038.61 | nM | Outside typical range |
| 90.782 | Ki | = | 90782.05 | nM | |
| 20.6063 | Ki | = | 20606.3 | nM | |
| 54.325 | Ki | = | 54325.03 | nM | |
| 30.6902 | Ki | = | 30690.22 | nM | |
| 136.144 | Ki | = | 136144.47 | nM | Outside typical range |
| 1448.77 | Ki | = | 1448771.85 | nM | Outside typical range |
| 38.9045 | Ki | = | 38904.51 | nM | |
| 1318.26 | Ki | = | 1318256.74 | nM | Outside typical range |
| 388.15 | Ki | = | 388150.37 | nM | Outside typical range |
| 258.821 | Ki | = | 258821.29 | nM | Outside typical range |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| pKa | = | 10.9 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.198 | Ki | = | 198 | nM |
| 0.442 | Ki | = | 442 | nM |
| 0.475 | Ki | = | 475 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 318 | Ki | = | 318000 | nM | Outside typical range |
| 63.1 | Ki | = | 63100 | nM | |
| 10700 | Ki | = | 10700000 | nM | Outside typical range |
| 5890 | Ki | = | 5890000 | nM | Outside typical range |
| 120 | Ki | = | 120000 | nM | Outside typical range |
| 898 | Ki | = | 898000 | nM | Outside typical range |
| 5770 | Ki | = | 5770000 | nM | Outside typical range |
| 352 | Ki | = | 352000 | nM | Outside typical range |
| 133 | Ki | = | 133000 | nM | Outside typical range |
| 2780 | Ki | = | 2780000 | nM | Outside typical range |
| 881 | Ki | = | 881000 | nM | Outside typical range |
| 652 | Ki | = | 652000 | nM | Outside typical range |
| 808 | Ki | = | 808000 | nM | Outside typical range |
| 4920 | Ki | = | 4920000 | nM | Outside typical range |
| 1180 | Ki | = | 1180000 | nM | Outside typical range |
| 3550 | Ki | = | 3550000 | nM | Outside typical range |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| pKa | = | 10.88 |
| pKa | = | 9.16 |
| pKa | = | 8.29 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 6 | IC50 | = | 6000 | nM | |
| 2757 | IC50 | = | 2757000 | nM | Outside typical range |
| 0.529 | Ki | = | 529 | nM | |
| 0.802 | Ki | = | 802 | nM | |
| 0.0978 | Ki | = | 97.8 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 0.5 | IC50 | = | 500 | nM | |
| 7 | IC50 | = | 7000 | nM | |
| 10 | IC50 | = | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 10 | IC50 | = | 10000 | nM | |
| 761.9 | IC50 | = | 761900 | nM | Outside typical range |
| 6.3 | IC50 | = | 6300 | nM | |
| 22.6 | IC50 | = | 22600 | nM | |
| 0.9 | IC50 | = | 900 | nM | |
| 2.4 | IC50 | = | 2400 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 18.9 | IC50 | = | 18900 | nM |
| 96.2 | IC50 | = | 96200 | nM |
| 11.3 | IC50 | = | 11300 | nM |
| 48.3 | IC50 | = | 48300 | nM |
| 8.3 | IC50 | = | 8300 | nM |
| 4.4 | IC50 | = | 4400 | nM |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| LogPapp | = | 1.16 |
| LogPapp | = | -0.64 |
| LogPapp | = | -1.32 |
| LogPapp | = | -0.38 |
| LogPapp | = | -1.17 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| pKa | = | 10.9 |
| pKa | = | 8.6 |
| pKa | = | 7.5 |
| pKa | = | 11.4 |
| pKa | = | 7.4 |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |
| Inhibition | = | 0.205 | % |
| Inhibition | < | 30 | % |
| Inhibition | < | 30 | % |